Syndey: Brazil and Malawi have shown the way to low-cost childhood cancer treatment in developing countries.
"Our findings mean it is time to re-evaluate global health policy," said Alexandra Martiniuk from the University of Sydney School of Public Health and The George Institute, who co-authored the study.
Worldwide, an estimated 175,000 children are diagnosed with cancer every year, approximately 90 percent of them living in low-and middle-income countries (LMIC), the journal Archives of Disease in Childhood reports.
In Australia, America and other high-income countries, about 90 percent of children with commonest types of cancer survive long term. But in poorer countries, the survival rates drop to between five and 40 percent, according to a Sydney statement.
"Resource-intensive medical services, such as chemotherapy and hospitalisation, are needed to cure childhood cancers so financial constraints are often cited as a barrier to their treatment in LMIC," said Martiniuk.
Researchers investigated the balance between health gains and financial costs by calculating the cost effectiveness of treatment of two kinds of childhood cancer: acute lymphocytic leukaemia in Brazil (in South America) and Burkitt lymphoma in Malawi (in Africa).
"Examining the actual costs to treat a child with cancer in Brazil and Malawi using globally recognised comparison ratios, we determined that the cost of treating a child with leukaemia in Brazil at $16,700. This is well below the globally recognised 1:1 ratio considered very cost effective," said Martiniuk.
The medical response for childhood cancers in the developed world includes intensive treatment, extensive support care and multiple hospital stays and is often considered prohibitively expensive for developed countries.
The study contradicts this assumption by showing that when a short course of treatment was used in Malawi for one month, 48 percent of children were cured.
The cost of chemotherapy and supportive care drugs in this instance was reported as less than $50 per child, representing less than one percent of the World Health Organisation`s calculated threshold for very cost effective treatment.
IANS
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.